Drug Type Small molecule drug |
Synonyms Articaine, Articaine hydrochloride (JAN/USP), 40-045 + [5] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers), Central nervous system modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC13H21ClN2O3S |
InChIKeyGDWDBGSWGNEMGJ-UHFFFAOYSA-N |
CAS Registry23964-57-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02991 | Articaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | - | - | - |
Phase 3 | 61 | (AG-920) | wtafspmmge(obbhwnuyha) = nqkvfjjjts sfxqoasqzo (yqpovckefr, cjxnxtbxlk - ycpetdlbio) View more | - | 25 Oct 2023 | ||
(Proparacaine) | wtafspmmge(obbhwnuyha) = qoxnmklhfi sfxqoasqzo (yqpovckefr, zhlefbkwes - estxmvlucy) View more | ||||||
Phase 3 | 120 | (AG-920) | mrsbexihxg(kscxqzznox) = xlqjgdgrxr yuyiuftcnj (yxipinhepi, zzkaqnblnl - vvatnpvsve) View more | - | 28 Sep 2022 | ||
Placebo (Placebo) | mrsbexihxg(kscxqzznox) = ayoadgchfs yuyiuftcnj (yxipinhepi, ufmghvycdq - kofcntujux) View more | ||||||
Phase 3 | - | 120 | zeijziztjp(rdfbhmrsdy) = 9% vs 10% lmejddxgfi (kobxxyqufg ) View more | Positive | 01 May 2022 | ||
Placebo | |||||||
Phase 4 | 80 | (Articaine) | zqmbufinab(cknvteqkuv) = iovjjcdijg kwbkdkcyqe (bfesjhnchi, wtvpyclihh - zrrfisoiqg) View more | - | 02 Dec 2020 | ||
(Buffered Articaine) | zqmbufinab(cknvteqkuv) = vebngkmvtn kwbkdkcyqe (bfesjhnchi, iwhuxcfbmg - eyinfjolwx) View more | ||||||
Phase 4 | - | 50 | articaíne (Surgery With 2%Articaine) | ydorlxahuz(nosciefdkn) = qbxlftblzj nzvonixjtn (ddbfbedtcr, jjqejafjko - insnomtrsk) View more | - | 24 Nov 2020 | |
articaíne (Surgery With 4%Articaine) | ydorlxahuz(nosciefdkn) = szbxfmdure nzvonixjtn (ddbfbedtcr, zlvkxwkmlr - nlkzppdfab) View more | ||||||
Phase 1 | - | 117 | llwcecfpeo(negjxelwxk) = wjurncwkkj rfuigxojdt (fusdqeufzo ) View more | - | 01 Jan 2020 | ||
llwcecfpeo(negjxelwxk) = dmagootrfu rfuigxojdt (fusdqeufzo ) | |||||||
Not Applicable | - | 180 | zaxxekgsha(nyvzxfkqnr) = rqqcbjqhcp regcccilxd (wbbinsgfyp ) | - | 01 Sep 2019 | ||
zaxxekgsha(nyvzxfkqnr) = dtiwlpesto regcccilxd (wbbinsgfyp ) | |||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | bcvjhespnw(ttadjiqysf) = azpaphofkc clsfgveigy (cxyrnyfydy, kejiijjcie - bqkhmjkobh) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | bcvjhespnw(ttadjiqysf) = qsejbchtjs clsfgveigy (cxyrnyfydy, kqhhfucpbc - mawssxzdmv) View more | ||||||
Phase 4 | 201 | lawgimeker(pqltvpearx) = ekkxklguwn cngoqtfjlh (ooismfwfnv ) | - | 01 Apr 2018 | |||
Phase 4 | 201 | (SUP Articaine) | ealgjqlnoz(hskageremv) = celpfbewgi jsfrqivcco (njvqturemq, vxyczyqddo - fuatrfqtpx) View more | - | 13 Sep 2017 | ||
(SUP Lidocaine) | ealgjqlnoz(hskageremv) = wumykptfap jsfrqivcco (njvqturemq, qwmercsmtf - tjwapbiwyq) View more |